tiprankstipranks
Advertisement
Advertisement

SLDB Stock Latest News

Solid Biosciences price target raised to $12 from $11 at JPMorgan
The FlySolid Biosciences price target raised to $12 from $11 at JPMorgan
16d ago
SLDB
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
17d ago
COYA
CTMX
Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating
PremiumRatings
Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating
18d ago
SLDB
Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows
PremiumCompany Announcements
Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows
20d ago
SLDB
Guggenheim starts Solid Biosciences with a Buy on DMD gene therapy potential
PremiumThe Fly
Guggenheim starts Solid Biosciences with a Buy on DMD gene therapy potential
21d ago
SLDB
SRPT
Solid Biosciences initiated with a Buy at Guggenheim
PremiumThe FlySolid Biosciences initiated with a Buy at Guggenheim
21d ago
SLDB
Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target
Premium
Ratings
Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target
21d ago
SLDB
Solid Biosciences files to sell 1.32M shares of common stock for holders
Premium
The Fly
Solid Biosciences files to sell 1.32M shares of common stock for holders
21d ago
SLDB
Solid Biosciences files to sell 42.78M shares of common stock for holders
PremiumThe Fly
Solid Biosciences files to sell 42.78M shares of common stock for holders
21d ago
SLDB
Solid Biosciences reports Q4 EPS (53c), consensus (52c)
PremiumThe Fly
Solid Biosciences reports Q4 EPS (53c), consensus (52c)
21d ago
SLDB
Buy Rating on SGT-003 Driven by Best-in-Class Efficacy Signals, Improving Safety, and Accelerated Approval Optionality
PremiumRatings
Buy Rating on SGT-003 Driven by Best-in-Class Efficacy Signals, Improving Safety, and Accelerated Approval Optionality
25d ago
SLDB
SLDB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
SLDB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
SLDB
Solid Biosciences price target raised to $17 from $14 at Wedbush
PremiumThe FlySolid Biosciences price target raised to $17 from $14 at Wedbush
29d ago
SLDB
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
Premium
Ratings
Solid Biosciences: INSPIRE DUCHENNE Data and FDA Pathway Support Overweight/Buy Rating on SGT-003 Gene Therapy Upside
29d ago
SLDB
Solid Biosciences Reports Encouraging Phase 1/2 Duchenne Data
Premium
Company Announcements
Solid Biosciences Reports Encouraging Phase 1/2 Duchenne Data
29d ago
8K
SLDB
Solid Biosciences: Strengthened Dystrophin Data and Emerging Cardiac Benefits Support Buy Rating on SGT-003
PremiumRatings
Solid Biosciences: Strengthened Dystrophin Data and Emerging Cardiac Benefits Support Buy Rating on SGT-003
29d ago
SLDB
Solid Biosciences trading resumes
PremiumThe Fly
Solid Biosciences trading resumes
30d ago
SLDB
Solid Biosciences says interim results reinforce confidence in SGT-003 potential
PremiumThe Fly
Solid Biosciences says interim results reinforce confidence in SGT-003 potential
30d ago
SLDB
Solid Biosciences trading halted, news pending
PremiumThe Fly
Solid Biosciences trading halted, news pending
30d ago
SLDB
Solid Biosciences Announces $240 Million Private Placement Financing
PremiumCompany AnnouncementsSolid Biosciences Announces $240 Million Private Placement Financing
1M ago
8K
SLDB
Solid Biosciences prices 14.97M shares at $5.61 in private placement
Premium
The Fly
Solid Biosciences prices 14.97M shares at $5.61 in private placement
1M ago
SLDB
Solid Biosciences reaches FDA alignment on IMPACT DUCHENNE study design
Premium
The Fly
Solid Biosciences reaches FDA alignment on IMPACT DUCHENNE study design
2M ago
SLDB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >